• Explore /
  • Poster
  • / Efficacy and safety of liposomal irinotecan (nal-IRI) + 5-fluorouracil and leucovorin (5-FU/LV) in patients (pts) with metastatic pancreatic ductal adenocarcinoma (mPDAC) who previously received gemcitabine (gem)-based therapy: Post-hoc analysis of the NAPOLI-1 trial.

Efficacy and safety of liposomal irinotecan (nal-IRI) + 5-fluorouracil and leucovorin (5-FU/LV) in patients (pts) with metastatic pancreatic ductal adenocarcinoma (mPDAC) who previously received gemcitabine (gem)-based therapy: Post-hoc analysis of the NAPOLI-1 trial.

Abstract Poster

Authors

null

Li-Tzong Chen

National Health Research Institutes- National Institute of Cancer Research, Tainan, Taiwan

Li-Tzong Chen , Andrea Wang-Gillam , Shan Yanshen , Teresa Macarulla , Jean-Frédéric Blanc , Richard Hubner , Chang-Fang Chiu , Gilberto Schwartsmann , Jens T. Siveke , J. Marc Pipas , Bruce Belanger , Floris de Jong , Khalid Mamlouk , Daniel D. Von Hoff

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel and Hepatobiliary Tract

Track

Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Sub Track

Translational Research

Clinical Trial Registration Number

NCT01494506

Citation

J Clin Oncol 35, 2017 (suppl 4S; abstract 303)

DOI

10.1200/JCO.2017.35.4_suppl.303

Abstract #

303

Poster Bd #

D17

Abstract Disclosures

Similar Posters

First Author: Daniel F. Gaddy

First Author: Benedikt Westphalen

First Author: Andrew L. Coveler

First Author: Gabriela Dieguez